{"id":"https://openalex.org/W3005772915","doi":"https://doi.org/10.1080/00207454.2020.1730832","title":"Tetrahydrocannabinol and cannabidiol oromucosal spray in resistant multiple sclerosis spasticity: consistency of response across subgroups from the SAVANT randomized clinical trial","display_name":"Tetrahydrocannabinol and cannabidiol oromucosal spray in resistant multiple sclerosis spasticity: consistency of response across subgroups from the SAVANT randomized clinical trial","publication_year":2020,"publication_date":"2020-02-17","ids":{"openalex":"https://openalex.org/W3005772915","doi":"https://doi.org/10.1080/00207454.2020.1730832","mag":"3005772915","pmid":"https://pubmed.ncbi.nlm.nih.gov/32065006"},"language":"en","primary_location":{"id":"doi:10.1080/00207454.2020.1730832","doi":"https://doi.org/10.1080/00207454.2020.1730832","is_oa":false,"landing_page_url":"https://doi.org/10.1080/00207454.2020.1730832","pdf_url":null,"source":{"id":"https://openalex.org/S78190159","display_name":"International Journal of Neuroscience","issn_l":"0020-7454","issn":["0020-7454","1026-7085","1543-5245","1563-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Neuroscience","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034872348","display_name":"Sven Guenther Meuth","orcid":"https://orcid.org/0000-0003-2571-3501","observed_orcids":["https://orcid.org/0000-0003-2571-3501"]},"institutions":[{"id":"https://openalex.org/I4210103666","display_name":"University Hospital M\u00fcnster","ror":"https://ror.org/01856cw59","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210103666"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Sven G Meuth","raw_affiliation_strings":["Department of Neurology with Institute of Translational Neurology, University Hospital Munster, Munster, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology with Institute of Translational Neurology, University Hospital Munster, Munster, Germany;","institution_ids":["https://openalex.org/I4210103666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088660055","display_name":"Thomas Henze","orcid":"https://orcid.org/0009-0007-3910-0411","observed_orcids":["https://orcid.org/0009-0007-3910-0411"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas Henze","raw_affiliation_strings":["Praxis F\u00fcr Neurologie, Regensburg, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Praxis F\u00fcr Neurologie, Regensburg, Germany;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038895594","display_name":"Ute Essner","orcid":"https://orcid.org/0000-0003-4502-0948","observed_orcids":["https://orcid.org/0000-0003-4502-0948"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ute Essner","raw_affiliation_strings":["O. Meany Consultancy GmbH, Hamburg, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"O. Meany Consultancy GmbH, Hamburg, Germany;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025044161","display_name":"Christiane Trompke","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158707","display_name":"Almirall (Germany)","ror":"https://ror.org/04v3pva14","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210122008","https://openalex.org/I4210158707"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Christiane Trompke","raw_affiliation_strings":["R&D, Almirall Hermal GmbH, Reinbek, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"R&D, Almirall Hermal GmbH, Reinbek, Germany;","institution_ids":["https://openalex.org/I4210158707"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5058239803","display_name":"Carlos Vila Silv\u00e1n","orcid":"https://orcid.org/0000-0001-5541-7848","observed_orcids":["https://orcid.org/0000-0001-5541-7848"]},"institutions":[{"id":"https://openalex.org/I4210122008","display_name":"Almirall (Spain)","ror":"https://ror.org/03qsven24","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210122008"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Carlos Vila Silv\u00e1n","raw_affiliation_strings":["Global Medical Affairs, Almirall S.A, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Medical Affairs, Almirall S.A, Barcelona, Spain","institution_ids":["https://openalex.org/I4210122008"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5034872348"],"corresponding_institution_ids":["https://openalex.org/I4210103666"],"apc_list":null,"apc_paid":null,"fwci":2.4429,"has_fulltext":false,"cited_by_count":29,"citation_normalized_percentile":{"value":0.87380485,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"130","issue":"12","first_page":"1199","last_page":"1205"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10414","display_name":"Cannabis and Cannabinoid Research","score":0.5439000129699707,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10414","display_name":"Cannabis and Cannabinoid Research","score":0.5439000129699707,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11274","display_name":"Botulinum Toxin and Related Neurological Disorders","score":0.4221000075340271,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.020899999886751175,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.7450000047683716},{"id":"https://openalex.org/keywords/spasticity","display_name":"spasticity","score":0.8949999809265137},{"id":"https://openalex.org/keywords/tetrahydrocannabinol","display_name":"tetrahydrocannabinol","score":0.8560000061988831},{"id":"https://openalex.org/keywords/cannabidiol","display_name":"cannabidiol","score":1.0},{"id":"https://openalex.org/keywords/nabiximols","display_name":"nabiximols","score":0.9909999966621399},{"id":"https://openalex.org/keywords/oromucosal-spray","display_name":"oromucosal spray","score":0.9670000076293945},{"id":"https://openalex.org/keywords/expanded-disability-status-scale","display_name":"Expanded Disability Status Scale","score":0.9449999928474426},{"id":"https://openalex.org/keywords/spasticity-severity","display_name":"spasticity severity","score":0.949999988079071},{"id":"https://openalex.org/keywords/subgroup-analysis","display_name":"subgroup analysis","score":0.8460000157356262}],"concepts":[{"id":"https://openalex.org/C2779012798","wikidata":"https://www.wikidata.org/wiki/Q117060","display_name":"Spasticity","level":2,"score":0.9340764880180359},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6875646114349365},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6065096259117126},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.5023565292358398},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.500952959060669},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.47867900133132935},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.4750361740589142},{"id":"https://openalex.org/C2780892749","wikidata":"https://www.wikidata.org/wiki/Q929518","display_name":"Expanded Disability Status Scale","level":3,"score":0.42910483479499817},{"id":"https://openalex.org/C99508421","wikidata":"https://www.wikidata.org/wiki/Q2678675","display_name":"Physical medicine and rehabilitation","level":1,"score":0.38774874806404114},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3040545880794525},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0875234305858612},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000700","descriptor_name":"Analgesics","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000700","descriptor_name":"Analgesics","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002185","descriptor_name":"Cannabidiol","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002185","descriptor_name":"Cannabidiol","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009103","descriptor_name":"Multiple Sclerosis","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D009128","descriptor_name":"Muscle Spasticity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009128","descriptor_name":"Muscle Spasticity","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013759","descriptor_name":"Dronabinol","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013759","descriptor_name":"Dronabinol","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017063","descriptor_name":"Outcome Assessment, Health Care","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058993","descriptor_name":"Oral Sprays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D063806","descriptor_name":"Myalgia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D063806","descriptor_name":"Myalgia","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1080/00207454.2020.1730832","doi":"https://doi.org/10.1080/00207454.2020.1730832","is_oa":false,"landing_page_url":"https://doi.org/10.1080/00207454.2020.1730832","pdf_url":null,"source":{"id":"https://openalex.org/S78190159","display_name":"International Journal of Neuroscience","issn_l":"0020-7454","issn":["0020-7454","1026-7085","1543-5245","1563-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Neuroscience","raw_type":"journal-article"},{"id":"pmid:32065006","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32065006","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The International journal of neuroscience","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":13,"referenced_works":["https://openalex.org/W1790460690","https://openalex.org/W1801725150","https://openalex.org/W1993448410","https://openalex.org/W2043053000","https://openalex.org/W2069564502","https://openalex.org/W2081270129","https://openalex.org/W2110690684","https://openalex.org/W2147062889","https://openalex.org/W2160528939","https://openalex.org/W2346483745","https://openalex.org/W2401020722","https://openalex.org/W2766145267","https://openalex.org/W2803556125"],"related_works":["https://openalex.org/W2803556125","https://openalex.org/W2876748213","https://openalex.org/W3020320100","https://openalex.org/W2530652964","https://openalex.org/W2624689004","https://openalex.org/W2594947450","https://openalex.org/W2134057375","https://openalex.org/W3049474527","https://openalex.org/W2909316501","https://openalex.org/W2345773636"],"abstract_inverted_index":{"Objective:":[0],"To":[1],"determine":[2],"whether":[3],"differences":[4],"in":[5,16,88,132,149,153,159,174,179,185,237],"disability":[6,92],"status,":[7],"spasticity":[8,11,23,63,101,113,129,140,156,161,182,187,198,206,211,218,227],"severity,":[9],"and":[10,71,99,110,112,117,130,158,184,210],"duration":[12,114,162,188],"at":[13],"treatment":[14,136,165],"start":[15],"patients":[17,223],"with":[18,214,224],"resistant":[19,197,216,226],"multiple":[20],"sclerosis":[21],"(MS)":[22],"might":[24],"influence":[25],"response":[26],"to":[27,81,108],"add-on":[28],"tetrahydrocannabinol:cannabidiol":[29],"(THC:CBD)":[30],"oromucosal":[31,121,192],"spray":[32,122,193],"(nabiximols)":[33,123,194],"versus":[34,143,172],"further":[35,52],"re-adjustment":[36],"of":[37,85],"optimized":[38,53],"first-line":[39,54],"antispasticity":[40],"medication.Methods:":[41],"Using":[42],"the":[43,46,154,175,180,238],"database":[44],"from":[45,78,145,221],"Sativex\u00ae":[47],"as":[48],"Add-on":[49,190],"therapy":[50],"Vs.":[51],"ANTispastics":[55],"(SAVANT)":[56],"study,":[57],"this":[58],"post":[59],"hoc":[60],"analysis":[61],"evaluated":[62],"severity":[64,73,102,126,141,170,207],"(0-10":[65],"numerical":[66],"rating":[67],"scale":[68,94],"[NRS]":[69],"scores)":[70,76],"pain":[72,131,169,233],"(0\u201310":[74],"NRS":[75,104,208],"evolution":[77],"randomization":[79],"(baseline)":[80],"week":[82,146],"12":[83],"(end":[84],"double-blind":[86],"treatment)":[87],"defined":[89,201],"subgroups:":[90],"Expanded":[91],"status":[93],"[EDSS]":[95],"score":[96,105,209],"subgroups":[97,106,115,200],"(<6":[98],"\u22656);":[100],"0-10":[103],"(4":[107],"\u22646":[109],">6),":[111],"(<5":[116],"\u22655":[118],"years).Results:":[119],"THC:CBD":[120,191],"halved":[124],"mean":[125,139,168],"scores":[127,142,171],"for":[128],"all":[133],"subgroups.":[134,163,240],"Active":[135,164],"significantly":[137,166],"improved":[138,167],"placebo":[144,173],"4":[147],"onwards":[148],"both":[150,160,186],"EDSS":[151,177,204],"subgroups,":[152],"severe":[155,181,225],"subgroup,":[157,178],"\u22656":[176],"subgroup":[183],"subgroups.Conclusion:":[189],"consistently":[195],"relieves":[196],"across":[199],"by":[202],"baseline":[203],"score,":[205],"duration.":[212],"Patients":[213],"moderate":[215],"MS":[217],"benefit":[219],"numerically":[220],"treatment;":[222],"achieve":[228],"significant":[229],"therapeutic":[230],"gains.":[231],"Spasticity-associated":[232],"often":[234],"improves":[235],"similarly":[236],"same":[239]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2020-02-24T00:00:00"}